brentuximab vedotin
takeda,seagen
['lymsm', 'brentuximab vedotin', 'improve', 'hodgkin', 'lymphoma']
frontline brentuximab vedotin plus chemotherapy improves 6-year survival in hodgkin lymphoma #asco22 #lymsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.